COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 1662: Articles 16611-16620  | Next

High-Potency Polypeptide-based Interference for Coronavirus Spike Glycoproteins
Ma, J., Campos Acevedo, A., Wang, Q.
10.1101/2021.04.05.438537 — Posted: 2021-04-06
Plasma microbiome in COVID-19 subjects: an indicator of gut barrier defects and dysbiosis
Prasad, R., Patton, M. J., Floyd, J. L., Vieira, C. P., Fortmann, S. D., DuPont, M., Harbour, A., Chen See, J. R., Wright, J., Lamendella, R., Stevens, B. R., Grant, M. B.
10.1101/2021.04.06.438634 — Posted: 2021-04-06
Murine monoclonal antibodies against RBD of SARS-CoV-2 neutralize authentic wild type SARS-CoV-2 as well as B.1.1.7 and B.1.351 viruses and protect in vivo in a mouse model in a neutralization dependent manner
Amanat, F., Strohmeier, S., Lee, W.-H., Bangaru, S., Ward, A. B., Coughlan, L., Krammer, F.
10.1101/2021.04.05.438547 — Posted: 2021-04-06
Unique protein features of SARS-CoV-2 relative to other Sarbecoviruses
Cotten, M., Robertson, D. L., Phan, M. V. T.
10.1101/2021.04.06.438675 — Posted: 2021-04-06
Effects of worldwide interventions and vaccination on COVID-19 between waves and countries
Ge, Y., Zhang, W., Liu, H., Ruktanonchai, C. W., Hu, M., Wu, X., Song, Y., Ruktanonchai, N. W., Yan, W., Feng, L., Li, Z., Yang, W., Liu, M., Tatem, A. J., Lai, S.
10.1101/2021.03.31.21254702 — Posted: 2021-04-06
Covid-19 and excess mortality rates not comparable across countries
Kelly, G. E., Petti, S., Noah, N.
10.1101/2021.03.31.21254689 — Posted: 2021-04-06
Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis
Schrezenmeier, E. V., Bergfeld, L., Hillus, D., Lippert, J.-D., Weber, U., Tober-Lau, P., Landgraf, I., Schwarz, T., Kappert, K., Stefanski, A.-L., Sattler, A., Kotsch, K., Doerner, T., Sander, L. E., Budde, K., Halleck, F., Kurth, F., Corman, V. M., Choi, M.
10.1101/2021.03.31.21254683 — Posted: 2021-04-06
Wide application of minimally processed saliva on multiple RT-PCR kits for SARS-CoV-2 detection in Indonesia
Mahendra, C., Kaisar, M. M. M., Vasandani, S. R., Surja, S. S., Tjoa, E., Chriestya, F., Junusmin, K. I., Widowati, T. A., Irwanto, A., Ali, S.
10.1101/2021.04.01.21254743 — Posted: 2021-04-06
Tryptophan and arginine metabolism is significantly altered at the time of admission in hospital for severe COVID-19 patients: findings from longitudinal targeted metabolomics analysis
Ansone, L., Ustinova, M., Terentjeva, A., Perkons, I., Birzniece, L., Rovite, V., Rozentale, B., Viksna, L., Kolesova, O., Klavins, K., Klovins, J.
10.1101/2021.03.31.21254699 — Posted: 2021-04-06
Risk quantification for SARS-CoV-2 infection through airborne transmission in university settings
Ambatipudi, M., Carrillo Gonzalez, P., Tasnim, K., Daigle, J., Kulyk, T., Jeffreys, N., Sule, N., Trevino, R., He, E. M., Mooney, D., Koh, E. E.
10.1101/2021.03.31.21254731 — Posted: 2021-04-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).